Related Experiment Video
Updated: Jun 24, 2025

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
Association between magnesium depletion score and chronic obstructive pulmonary disease risk: a secondary data
Kai Jin Wang1, Hong Chen2, Jin Wang3
1Pulmonary and Critical Care Medicine, Bishan Hospital of Chongqing Medical University, Chongqing, China.
Background And Objective:
The association between magnesium depletion score (MDS) and the risk of chronic obstructive pulmonary disease (COPD) has not been examined to date. Meanwhile, the potential impact of dietary magnesium intake on this association remains unclear. This study aimed to investigate the influence of dietary magnesium intake on the association between MDS and COPD incidence.
Methods:
In this cross-sectional study using the National Health and Nutrition Examination Survey database, we analysed the relationship between MDS and COPD, while also exploring the role of dietary magnesium.
Results:
A total of 39 852 participants, including 1762 patients with COPD and 38 090 patients with non-COPD, were included in the analysis. After adjusting for confounding factors, our results demonstrated a significant association between higher MDS and increased COPD incidence (OR=1.48, 95% CI: 1.10 to 1.99). Furthermore, it was observed that dietary magnesium intake did not significantly impact this association.
Conclusion:
This study highlights a significant positive correlation between MDS and the incidence of COPD. Nonetheless, no significant alteration in this association was observed with dietary magnesium intake.
Insights
Higher magnesium depletion scores (MDS) are linked to increased chronic obstructive pulmonary disease (COPD) risk. Dietary magnesium intake did not alter this association in the study population.
Area of Science:
- Pulmonary Medicine
- Nutritional Science
- Epidemiology
Background:
- The relationship between magnesium depletion score (MDS) and chronic obstructive pulmonary disease (COPD) risk is not well-established.
- The influence of dietary magnesium intake on this potential association remains unclear.
Purpose of the Study:
- To investigate the association between magnesium depletion score (MDS) and the incidence of chronic obstructive pulmonary disease (COPD).
- To examine the role of dietary magnesium intake in modifying the relationship between MDS and COPD.
Main Methods:
- Cross-sectional study utilizing the National Health and Nutrition Examination Survey (NHANES) database.
- Analysis included 39,852 participants (1,762 with COPD).
- Adjusted for confounding factors to assess the relationship between MDS, dietary magnesium, and COPD incidence.
Main Results:
- A significant positive association was found between higher MDS and increased COPD incidence (OR=1.48, 95% CI: 1.10 to 1.99).
- Dietary magnesium intake did not significantly alter the association between MDS and COPD incidence.
Conclusions:
- Magnesium depletion score is significantly correlated with a higher incidence of COPD.
- Dietary magnesium intake does not appear to modify the association between magnesium depletion and COPD risk.
More Related Videos
Related Concept Videos
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation

